Healthcare cos see a Covid lining, line up to raise record money

[ad_1]

Pune-based Emcure Pharmaceuticals, a generic drug maker has initiated plans for Rs 3,500-4,000 crore IPO and is consulting funding bankers to begin work on documentation.

Synopsis

At least 12 drug makers and healthcare firms are planning IPOs in 2021 because the pandemic will increase investor demand for the promising gamers in associated sectors

Mumbai: India’s major market is probably going to witness record fund elevating by pharma, healthcare and associated firms in 2021 as buyers scout for corporations that might profit from the Covid-19 pandemic. Initial public choices of at the very least 12 drug makers and healthcare firms are within the offing in 2021, in accordance to bankers. In the previous 5 years, solely seven firms concerned within the sector have hit the IPO market.

These firms are in

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Sign in to learn the total article

You’ve obtained this Prime Story as a Free Gift

Already a Member?

Special Offer on ET Prime

Subscribe to ET Prime – Get Flat 20% Off

View Plans

Special Offer on ET Prime

Subscribe to ET Prime – Get 25% Off

View Plans

Special Offer on ET Prime

Subscribe to ET Prime – Get 25% Off

View Plans

Why ?

  • Sharp Insight-rich, Indepth tales throughout 20+ sectors

  • Access the unique Economic Times tales, Editorial and Expert opinion

  • Clean expertise with
    Minimal Ads

  • Comment & Engage with ET Prime group

  • Exclusive invitations to Virtual Events with Industry Leaders

  • A trusted group of Journalists & Analysts who can greatest filter sign from noise

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *